glp-1 vs glp-1/gip The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Upcoming wave of hormone-based therapies
Description
doi:10.1016/B978-0-12-384964-9.00011-6
The SURMOUNT trials ran for 72 weeks with similar weight regain patterns after discontinuation
Whats Included Monthly medication, a personalized SmartDose titration plan, an online consultation, behavior coaching, the Noom app, injection videos, and care-team messaging
however, human studies have not revealed significant abnormalities with first-trimester exposure
Anti-inflammatory and Antifibrotic Effects Chronic inflammation and myocardial fibrosis are hallmarks of HF progression
Fybogel Orange Granules Summary of Product Characteristics (EMC)
